{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:15:10Z","timestamp":1775744110107,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ekir.2024.07.034","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T01:24:29Z","timestamp":1723080269000},"page":"3134-3144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Systematic Review of Individual Patient Data COVID-19 Infection and Vaccination\u2013Associated Thrombotic Microangiopathy"],"prefix":"10.1016","volume":"9","author":[{"given":"Pujan","family":"Moradiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8753-1837","authenticated-orcid":false,"given":"Priyanka","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupesh","family":"Raina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruchi Gupta","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2024.07.034_bib1","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/S0140-6736(22)01202-8","article-title":"Haemolytic uraemic syndrome","volume":"400","author":"Michael","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2024.07.034_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123580","article-title":"Pediatric atypical hemolytic uremic syndrome advances","volume":"10","author":"Raina","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ekir.2024.07.034_bib3","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00467-021-05370-8","article-title":"Thrombotic microangiopathy in children","volume":"37","author":"Palma","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2024.07.034_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/ckj\/sfy066","article-title":"Atypical hemolytic uremic syndrome: a syndrome in need of clarity","volume":"12","author":"Berger","year":"2019","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2024.07.034_bib5","doi-asserted-by":"crossref","first-page":"e537","DOI":"10.1016\/S2352-3026(16)30125-9","article-title":"Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy","volume":"3","author":"Joly","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ekir.2024.07.034_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41581-021-00424-4","article-title":"Thrombotic microaniopathy in aHUS and beyond: clinical clues from complement genetics","volume":"17","author":"Fakhouri","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2024.07.034_bib7","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.ekir.2023.05.010","article-title":"Complement-mediated thrombotic microangiopathy related to COVID-19 or SARS-CoV-2 vaccination","volume":"8","author":"Aigner","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2024.07.034_bib8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome","volume":"33","author":"Kavanagh","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ekir.2024.07.034_bib9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2024.07.034_bib10","first-page":"1373","article-title":"Eculizumab treatment for renal failure in a pediatric patient with COVID-19","volume":"33","author":"Mahajan","year":"2020","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.ekir.2024.07.034_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.931210","article-title":"Anti-factor H antibody and its role in atypical hemolytic uremic syndrome","volume":"13","author":"Raina","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ekir.2024.07.034_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abh2259","article-title":"Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection","volume":"6","author":"Ma","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ekir.2024.07.034_bib13","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3324\/haematol.2021.279155","article-title":"Complement dysregulation is associated with severe COVID-19 illness","volume":"107","author":"Yu","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.ekir.2024.07.034_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2442","article-title":"Biomarkers of endothelial dysfunction are associated with poor outcome in COVID-19 patients: a systematic review and meta-analysis","volume":"33","author":"Mohebbi","year":"2023","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.ekir.2024.07.034_bib15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41584-020-0448-7","article-title":"Autoimmune and inflammatory diseases following COVID-19","volume":"16","author":"Galeotti","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ekir.2024.07.034_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102898","article-title":"Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review","volume":"132","author":"Rodriguez","year":"2022","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.ekir.2024.07.034_bib21","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ekir.2024.07.034_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28946","article-title":"New-onset and relapsed thrombotic microangiopathy post-COVID-19 vaccination","volume":"95","author":"Ma","year":"2023","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.ekir.2024.07.034_bib23","first-page":"317","article-title":"New insights into kidney disease after COVID-19 infection and vaccination: histopathological and clinical findings","volume":"117","author":"Li","year":"2023","journal-title":"Q\u00a0J M"},{"key":"10.1016\/j.ekir.2024.07.034_bib24","article-title":"New-onset and relapsed kidney histopathology following COVID-19 vaccination: a systematic review","volume":"9","author":"Wu","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ekir.2024.07.034_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.thromres.2022.04.020","article-title":"Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: a systematic review of reported cases","volume":"214","author":"Saluja","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.ekir.2024.07.034_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911307","article-title":"Coronavirus disease 2019-associated thrombotic microangiopathy: literature review","volume":"23","author":"Malgaj Vrecko","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ekir.2024.07.034_bib27","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1182\/blood.2020009150","article-title":"Redefining outcomes in immune TTP: an international working group consensus report","volume":"137","author":"Cuker","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2024.07.034_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5144\/1658-3876.2011.51","article-title":"Viral-associated thrombotic microangiopathies","volume":"4","author":"Lopes da Silva","year":"2011","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.ekir.2024.07.034_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.100995","article-title":"Complement activation in COVID-19 and targeted therapeutic options: a scoping review","volume":"57","author":"Lim","year":"2023","journal-title":"Blood Rev"},{"key":"10.1016\/j.ekir.2024.07.034_bib30","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.2020008248","article-title":"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2024.07.034_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261113","article-title":"Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: retrospective cohort study","volume":"16","author":"Ruggenenti","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2024.07.034_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100590","article-title":"Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: a proof-of-concept study","volume":"28","author":"Annane","year":"2020","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.ekir.2024.07.034_bib33","first-page":"156","article-title":"Clinical features and risk factors of relapse and mortality in thrombotic thrombocytopenic purpura patients: a seven-year experience","volume":"17","author":"Tavakoli","year":"2023","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"10.1016\/j.ekir.2024.07.034_bib34","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"115","author":"Kremer Hovinga","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2024.07.034_bib35","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3324\/haematol.2011.049676","article-title":"Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience","volume":"97","author":"Benhamou","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.ekir.2024.07.034_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2176","article-title":"Covid-19 and kidney injury: pathophysiology and molecular mechanisms","volume":"31","author":"Ahmadian","year":"2021","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.ekir.2024.07.034_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.thromres.2022.08.017","article-title":"Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: a systematic review and meta-analysis","volume":"218","author":"Xu","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.ekir.2024.07.034_bib38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2024.07.034_bib39","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1505533","article-title":"Caplacizumab for acquired thrombotic thrombocytopenic purpura","volume":"374","author":"Peyvandi","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2024.07.034_bib40","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ekir.2024.07.034_bib41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.coi.2021.04.005","article-title":"Membrane cofactor protein (MCP; CD46): deficiency states and pathogen connections","volume":"72","author":"Liszewski","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ekir.2024.07.034_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11082287","article-title":"Spikeopathy\u2019: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA","volume":"11","author":"Parry","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ekir.2024.07.034_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1056153","article-title":"COVID-19 vaccination and atypical hemolytic uremic syndrome","volume":"13","author":"Bouwmeester","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ekir.2024.07.034_bib44","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00277-022-04774-2","article-title":"No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey","volume":"101","author":"Hamada","year":"2022","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ekir.2024.07.034_bib45","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.3324\/haematol.2022.280702","article-title":"Relapse of immune-mediated thrombotic thrombocytopenic purpura following mRNA COVID-19 vaccination: a prospective cohort study","volume":"107","author":"Giuffrida","year":"2022","journal-title":"Haematologica"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024924018643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024924018643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T09:14:37Z","timestamp":1730711677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024924018643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2468024924018643"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2024.07.034","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Review of Individual Patient Data COVID-19 Infection and Vaccination\u2013Associated Thrombotic Microangiopathy","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2024.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier, Inc., on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}